155 related articles for article (PubMed ID: 20636678)
1. Is there variability in drug release and physical characteristics of amiodarone chloride from different commercially available tablets? Possible therapeutic implications.
Ngo SN; Barnes T
Int J Pharm Pract; 2010 Aug; 18(4):245-8. PubMed ID: 20636678
[TBL] [Abstract][Full Text] [Related]
2. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.
Lima DM; dos Santos LD; Lima EM
J Pharm Biomed Anal; 2008 Aug; 47(4-5):934-7. PubMed ID: 18472382
[TBL] [Abstract][Full Text] [Related]
3. Disintegration/dissolution profiles of copies of Fosamax (alendronate).
Epstein S; Cryer B; Ragi S; Zanchetta JR; Walliser J; Chow J; Johnson MA; Leyes AE
Curr Med Res Opin; 2003; 19(8):781-9. PubMed ID: 14687450
[TBL] [Abstract][Full Text] [Related]
4. Comparison of simvastatin tablets from the US and international markets obtained via the Internet.
Veronin MA; Nguyen NT
Ann Pharmacother; 2008 May; 42(5):613-20. PubMed ID: 18413690
[TBL] [Abstract][Full Text] [Related]
5. The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution.
Kayumba PC; Risha PG; Shewiyo D; Msami A; Masuki G; Ameye D; Vergote G; Ntawukuliryayo JD; Remon JP; Vervaet C
J Clin Pharm Ther; 2004 Aug; 29(4):331-8. PubMed ID: 15271100
[TBL] [Abstract][Full Text] [Related]
6. In vitro dissolution test of tamoxifen citrate preparations.
Braga RM; Carvalho RD; Fonseca SG; Strattmann R; De Santana DP; De Albuquerque MM
Boll Chim Farm; 2001; 140(6):467-70. PubMed ID: 11822241
[TBL] [Abstract][Full Text] [Related]
7. Clozapine repackaged into dose administration aids: a common practice in Australian hospitals.
Perks S; Robertson S; Haywood A; Glass B
Int J Pharm Pract; 2012 Feb; 20(1):4-8. PubMed ID: 22236174
[TBL] [Abstract][Full Text] [Related]
8. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
Strauch S; Jantratid E; Dressman JB
J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
[TBL] [Abstract][Full Text] [Related]
9. In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.
Walker AD; Adachi JD
Curr Med Res Opin; 2011 Sep; 27(9):1749-54. PubMed ID: 21781014
[TBL] [Abstract][Full Text] [Related]
10. Study of accelerated storage conditions affecting physical characteristics, in-vitro dissolution and stability of bioadhesive containing tablets.
Hosny EA
Boll Chim Farm; 1999 Jun; 138(6):243-8. PubMed ID: 10464972
[TBL] [Abstract][Full Text] [Related]
11. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
12. Selection of generic preparations of famotidine orally disintegrating tablets for use in unit-dose packages.
Yamazaki N; Iizuka R; Miyazawa S; Wada Y; Shimokawa K; Ishii F
Drug Discov Ther; 2012 Oct; 6(5):263-8. PubMed ID: 23229147
[TBL] [Abstract][Full Text] [Related]
13. Altered metabolite concentrations with amiodarone generic substitution cannot be observed without monitoring.
Pollak PT
Can J Cardiol; 2001 Nov; 17(11):1159-63. PubMed ID: 11726984
[TBL] [Abstract][Full Text] [Related]
14. Physiochemical properties of generic formulations of tacrolimus in Mexico.
Petan JA; Undre N; First MR; Saito K; Ohara T; Iwabe O; Mimura H; Suzuki M; Kitamura S
Transplant Proc; 2008 Jun; 40(5):1439-42. PubMed ID: 18589125
[TBL] [Abstract][Full Text] [Related]
15. Adjusting dissolution specifications for the variability induced by storage conditions.
Reynolds JM; Rogers DH
J Biopharm Stat; 2000 Aug; 10(3):425-31. PubMed ID: 10959921
[TBL] [Abstract][Full Text] [Related]
16. Multiple-layer compression-coated tablets: formulation and humidity studies of novel chewable amoxicillin/clavulanate tablet formulations.
Wardrop J; Jaber AB; Ayres JW
Drug Dev Ind Pharm; 1998 Aug; 24(8):729-36. PubMed ID: 9876520
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
[TBL] [Abstract][Full Text] [Related]
18. Effect on dissolution of tablet storage in counting machines.
Knapp GG; Page DP
Am J Hosp Pharm; 1983 Apr; 40(4):623-5. PubMed ID: 6846373
[TBL] [Abstract][Full Text] [Related]
19. Comparative stability of repackaged metoprolol tartrate tablets.
Yang Y; Gupta A; Carlin AS; Faustino PJ; Lyon RC; Ellison CD; Rothman B; Khan MA
Int J Pharm; 2010 Jan; 385(1-2):92-7. PubMed ID: 19879937
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dissolution properties of 2 enteric-coated formulations containing mycophenolate sodium: Myfortic vs Femulan.
Esquivel A; González-Ramírez R; Alberú J; Gracida C; Medeiros M; Castañeda-Hernández G
Transplant Proc; 2010; 42(1):353-6. PubMed ID: 20172348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
